TLVAX | VIMSX | TLVAX / VIMSX | |
Total Expense Ratio | 1.29 | 0.17 | 759% |
Annual Report Gross Expense Ratio | 1.49 | 0.17 | 876% |
Fund Existence | 26 years | 27 years | - |
Gain YTD | 6.868 | 8.291 | 83% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 328M | 197B | 0% |
Annual Yield % from dividends | 0.43 | 1.37 | 31% |
Returns for 1 year | -4.77 | 14.31 | -33% |
Returns for 3 years | 9.42 | 26.39 | 36% |
Returns for 5 years | 38.81 | 62.16 | 62% |
Returns for 10 years | 27.80 | 125.09 | 22% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TAISX | 13.44 | 0.05 | +0.37% |
Nuveen Quant Intl Small Cap Eq I | |||
GFACX | 72.53 | -0.05 | -0.07% |
American Funds Growth Fund of Amer C | |||
MCSPX | 11.21 | -0.02 | -0.18% |
BlackRock Advantage SMID Cap Inv C | |||
SCDGX | 37.19 | -0.13 | -0.35% |
DWS Core Equity S | |||
MRLTX | 19.19 | -0.09 | -0.47% |
AMG Renaissance Large Cap Growth N |